T

T Kozu

Musashino Red Cross Hospital

Publishes on Acute Myeloid Leukemia Research, Advanced biosensing and bioanalysis techniques, DNA and Nucleic Acid Chemistry. 15 papers and 2k citations.

15Publications
2kTotal Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.
H Miyoshi, K Shimizu, T Kozu et al.|Proceedings of the National Academy of Sciences|1991
Cited by 883Open Access

The t(8;21)(q22;q22) translocation is a non-random chromosomal abnormality frequently found in patients with acute myeloid leukemia (AML) with maturation (M2 subtype). We report here the cloning of a gene, named AML1, on chromosome 21 that was found to be rearranged in the leukemic cell DNAs from t(8;21) AML patients. The breakpoints in 16 out of 21 patients were clustered within a limited region of AML1, and detailed analysis in 3 patients revealed that the breakpoints occurred in the same intron of the gene. Sequencing of cDNA clones identified a long open reading frame encoding a 250-amino acid protein. Northern blot analysis detected four constant mRNA species in t(8;21) leukemic and normal cells; the largest species was more abundant in the leukemic cells than in normal cells. In addition, two mRNA species limited to the leukemic cells were found. These findings indicate that the AML1 gene may be involved in neoplastic transformation of AML with the t(8;21) translocation.

Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction
T Kozu, Hiroyuki Miyoshi, K Shimizu et al.|Blood|1993
Cited by 137Open Access

The chromosomal translocation, t(8;21), is found frequently in acute myeloid leukemia (AML) with maturation (FAB-M2). We have previously mapped the translocation breakpoints of t(8;21) in a specific intron of the AML1 gene on chromosome 21. In this study, we cloned cDNAs synthesized from a cell line carrying t(8;21) by reverse transcription polymerase chain reaction (RT-PCR) using an AML1-specific primer. The analysis of the cDNAs structure has led to the identification of the fusion of AML1 with a gene named MTG8 on chromosome 8, which seems to be identical to ETO. Northern analysis using MTG8 (ETO) probes detected 7.8-kb and 6.2-kb RNAs and several minor RNAs in the cell line with t(8;21), but failed to detect any transcripts in a cell line without t(8;21). A set of primers were designed to detect the AML1/MTG8(ETO) fusion by PCR. The PCR amplified identical products in all 6 patients and one cell line with t(8;21), suggesting that the AML1/MTG8(ETO) fusion is a constant feature associated with t(8;21) and the junctions of the AML1/MTG8(ETO) fusion are restricted in a unique site. Because the PCR detection of the AML1/MTG8(ETO) fusion at the RNA level is highly sensitive, it can be used as a sensitive method for diagnosis and detection of minimal residual disease in t(8;21) leukemia.

Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
Cited by 93

Heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 is an RNA binding protein that is required for maturation of mRNA precursor. Tockman et al. previously reported that hnRNP A2/B1 with a M(r) of 31,000 is overexpressed from the early clinical stage of human lung cancer (M. S. Tockman et al., J. Clin. Oncol., 6: 1685-1693, 1988). However, when hnRNP A2/B1 mRNA and hnRNP B1 mRNA were separately studied, we found unique evidence that hnRNP B1 mRNA, which is a splicing variant of hnRNP A2 mRNA, was more significantly elevated in lung cancer tissues than hnRNP A2/B1 mRNA. Our hnRNP B1-specific polyclonal antibody specifically recognized hnRNP B1 protein as a M(r) 37,000 nuclear protein by Western blotting but did not recognize hnRNP A2 protein. Immunohistochemical staining with the hnRNP B1 antibody revealed that hnRNP B1 protein was specifically stained in the nuclei of human cancer cells, and in squamous cell carcinomas in particular, but not in those of normal adjacent lung epithelial cells. We think that hnRNP B1 protein of M(r) 37,000, not hnRNP A2, is well qualified as a biomarker for the detection of human lung cancer.

Mouse DNA replicase. DNA polymerase associated with a novel RNA polymerase activity to synthesize initiator RNA of strict size.
Tatsuo Yagura, T Kozu, Tetsuzo Seno|Journal of Biological Chemistry|1982
Cited by 82Open Access

De novo DNA synthesis on poly(dT) by a novel mouse DNA polymerase, here named "DNA replicase," was examined for the synthesis of RNA which functions as a primer in the subsequent synthesis of DNA. As has been reported previously (Yagura, T., Kozu, T., and Seno, T. (1982) J. Biochem. (Tokyo) 91, 607-618), a novel RNA polymerase activity, which is distinguished from those of classical RNA polymerases, is associated with DNA replicase. The synthesis of RNA and DNA by DNA replicase (Mr = 16 X 10(4), by glycerol gradient sedimentation analysis) was greatly stimulated by a specific stimulating factor (Mr = 13 X 10(4), by glycerol gradient sedimentation analysis) which was found to consist of two subunits (Mr = 63 X 10(3), by sodium dodecyl sulfate-polyacrylamide gel electrophoresis). Nearest neighbor analysis in which transfer of 32P from alpha-labeled nucleoside triphosphates to ribo- and deoxyribonucleotides was examined, showed th at RNA of 8-10 nucleotides long was covalently linked to the 5'-end of the DNA product molecule. This RNA, named initiator RNA, had a triphosphate group at its 5' terminus and its size and synthesis were little affected by the addition of high concentrations of deoxynucleoside triphosphate, while in these conditions deoxyribonucleotides were incorporated into initiator RNA to a limited extent. The characteristics of the DNA replicase and stimulating factor that cooperate to synthesize initiator RNA for subsequent DNA synthesis on single-stranded DNA are important because these components seem to be involved in a reaction required to initiate the synthesis of discontinuous earliest DNA intermediates (Okazaki fragments) in chromosomal DNA replication of eukaryotic cells.